CoChat

Melatonin and its metabolites protect human melanocytes against UVB-induced damage: Involvement of NRF2-mediated pathways

Open access
Janjetovic, Zorica, Jarrett, Stuart G., Lee, Elizabeth F., Duprey, Cory, Reiter, Russel J., Slominski, Andrzej T. · 2017 · Scientific Reports

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

Ultraviolet light (UV) is an inducer of reactive oxygen species (ROS) as well as 6-4-photoproducts and cyclobutane pyrimidine dimers (CPD) in the skin, which further cause damage to the skin cells. Irradiation of cultured human melanocytes with UVB stimulated ROS production, which was reduced in cells treated with melatonin or its metabolites: 6-hydroxymelatonin (6-OHM), N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), N-acetylserotonin (NAS), and 5-methoxytryptamine (5-MT). Melatonin and its derivatives also stimulated the expression of NRF2 (nuclear factor erythroid 2 [NF-E2]-related factor 2) and its target enzymes and proteins that play an important role in cell protection from different damaging factors including UVB. Silencing of NRF2 using siRNA diminished the protective effects of melatonin, while the membrane melatonin receptors (MT1 or MT2) did not change the activities of either melatonin or its derivatives. Melatonin and its metabolites enhanced the DNA repair in melanocytes exposed to UVB and stimulated expression of p53 phosphorylated at Ser-15. In conclusion, melatonin and its metabolites protect melanocytes from UVB-induced DNA damage and oxidative stress through activation of NRF2-dependent pathways; these actions are independent of an effect on the classic membrane melatonin receptors. Thus, melatonin and its derivatives can serve as excellent protectors of melanocytes against UVB-induced pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-01305-2

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Melatonin, NAS, 6-OHM, AFMK, and 5-MT reduce UVB-induced oxidative stress. UVB-irradiated (25 mJ/cm2) and non-irradiated melanocytes (comparison presented as inserts) were treated with melatonin or its metabolites for 24 h prior UV irradiation at the concentration 5 × 10−5 M. NO-(a) or H2O2 (b) produced in melanocytes were determined 30 min after UVB irradiation, while GSH levels (c) were determined 1 h post UVB. Data were analyzed using student t-test, *p < 0.05, **p < 0.01.
Figure 1 Melatonin, NAS, 6-OHM, AFMK, and 5-MT reduce UVB-induced oxidative stress. UVB-irradiated (25 mJ/cm2) and non-irradiated melanocytes (comparison presented as inserts) were treated with melatonin or its metabolites for 24 h prior UV irradiation at the concentration 5 × 10−5 M. NO-(a) or H2O2 (b) produced in melanocytes were determined 30 min after UVB irradiation, while GSH levels (c) were determined 1 h post UVB. Data were analyzed using student t-test, *p < 0.05, **p < 0.01.CC BY · PubMed Central
Figure 2 Melatonin, NAS, 6-OHM, AFMK, and 5-MT exhibit repair capacities in UVB-induced DNA damage in treated melanocytes as shown by reduced levels of CPD and comet cell tail moments. Cells were treated with melatonin or its metabolites for 24 h prior UV irradiation at the concentration 5 × 10−5 M, further exposed to UVB intensities of 25 or 50 mJ/cm2 and immediately treated again with melatonin or its derivatives for 3 h. Cells were fixed and stained with anti-CPD antibody and further imaged with a fluorescence microscope. Fluorescence intensity was analysed using ImageJ software and data were analysed using Graph Pad Prizm. CPD formation under different UVB intensity levels are shown in (a). Figure presents CPD levels after 0 mJ/cm2 (b), 25 mJ/cm2 (c) and 50 mJ/cm2 (d). Data are presented as percentile of control and were analyzed using t- test, *p < 0.05, **p < 0.01. As an example, images of the melanocytes stained with CPD antibody (green) and nuclear staining with propidium iodine (red) show no CPD signal in non-irradiated melanocytes (UV−) and positive CPD signal in UVB (25 mJ/cm2) irradiated cells (UV+) (magnification 20x). Also, melanocytes were treated with melatonin or its metabolites before and after UV irradiation (200 mJ/cm3). Tail moment is an index of DNA damage. Data are analysed using student t-test and p < 0.001 for all conditions (e).
Figure 2 Melatonin, NAS, 6-OHM, AFMK, and 5-MT exhibit repair capacities in UVB-induced DNA damage in treated melanocytes as shown by reduced levels of CPD and comet cell tail moments. Cells were treated with melatonin or its metabolites for 24 h prior UV irradiation at the concentration 5 × 10−5 M, further exposed to UVB intensities of 25 or 50 mJ/cm2 and immediately treated again with melatonin or its derivatives for 3 h. Cells were fixed and stained with anti-CPD antibody and further imaged with a fluorescence microscope. Fluorescence intensity was analysed using ImageJ software and data were analysed using Graph Pad Prizm. CPD formation under different UVB intensity levels are shown in (a). Figure presents CPD levels after 0 mJ/cm2 (b), 25 mJ/cm2 (c) and 50 mJ/cm2 (d). Data are presented as percentile of control and were analyzed using t- test, *p < 0.05, **p < 0.01. As an example, images of the melanocytes stained with CPD antibody (green) and nuclear staining with propidium iodine (red) show no CPD signal in non-irradiated melanocytes (UV−) and positive CPD signal in UVB (25 mJ/cm2) irradiated cells (UV+) (magnification 20x). Also, melanocytes were treated with melatonin or its metabolites before and after UV irradiation (200 mJ/cm3). Tail moment is an index of DNA damage. Data are analysed using student t-test and p < 0.001 for all conditions (e).CC BY · PubMed Central
Figure 3 UVB irradiation intensifies p53 levels. Melatonin, NAS, 6-OHM, AFMK, and 5-MT treated HEMn elevated levels of p53 phosphorylated at Serine 15 after UVB exposure. Melanocytes were treated with melatonin or its metabolites for 24 h before UVB exposure. Cells were exposed to UVB intensities of 25 (a), or 50 mJ/cm2 (b) and immediately treated again with melatonin or its derivatives for 12 h. Cells were further fixed and stained with anti-phosphorylated p53S15 antibody. Stained cells were imaged with a fluorescence microscope; fluorescence intensity was analysed using ImageJ software. P53 levels increased proportional to UVB intensity (insert). Data are analysed using Graph Pad Prizm. Data are presented as percentile of control and were analyzed using t- test, *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 3 UVB irradiation intensifies p53 levels. Melatonin, NAS, 6-OHM, AFMK, and 5-MT treated HEMn elevated levels of p53 phosphorylated at Serine 15 after UVB exposure. Melanocytes were treated with melatonin or its metabolites for 24 h before UVB exposure. Cells were exposed to UVB intensities of 25 (a), or 50 mJ/cm2 (b) and immediately treated again with melatonin or its derivatives for 12 h. Cells were further fixed and stained with anti-phosphorylated p53S15 antibody. Stained cells were imaged with a fluorescence microscope; fluorescence intensity was analysed using ImageJ software. P53 levels increased proportional to UVB intensity (insert). Data are analysed using Graph Pad Prizm. Data are presented as percentile of control and were analyzed using t- test, *p < 0.05, **p < 0.01, ***p < 0.001.CC BY · PubMed Central
Figure 4 Melatonin and its metabolites enhance the XPC- and XPA-DNA-interaction. Melanocytes were treated with melatonin or its metabolites for 24 h in complete melanocyte medium. Cells were further exposed to either (a) non UVB-treated (0 mJ/cm2) or (b) 25 mJ/cm2 or (c) 50 mJ/cm2. Synthetic oligonucleotides (Molecular Beacons) were assembled to form 5′-biotinylated duplex DNA fragment. The substrate provides a substrate for NER proteins and DNA-protein interactions were determined using anti-XPC and anti-XPA antibodies as described in the Methods. Treatments significantly different from vehicle were determined by one-way ANOVA; *p ≤ 0.05. All treatments in B or C were statistically significant when compared to vehicle.
Figure 4 Melatonin and its metabolites enhance the XPC- and XPA-DNA-interaction. Melanocytes were treated with melatonin or its metabolites for 24 h in complete melanocyte medium. Cells were further exposed to either (a) non UVB-treated (0 mJ/cm2) or (b) 25 mJ/cm2 or (c) 50 mJ/cm2. Synthetic oligonucleotides (Molecular Beacons) were assembled to form 5′-biotinylated duplex DNA fragment. The substrate provides a substrate for NER proteins and DNA-protein interactions were determined using anti-XPC and anti-XPA antibodies as described in the Methods. Treatments significantly different from vehicle were determined by one-way ANOVA; *p ≤ 0.05. All treatments in B or C were statistically significant when compared to vehicle.CC BY · PubMed Central
Figure 5 Melatonin, NAS, 6-OHM, AFMK, and 5-MT reduce levels of ROS produced in UVB-irradiated melanocytes. Cells were treated without (a,b) or with (c,d) luzindole 1 h prior treatment with melatonin, AFMK, 6-OHT, 5-MT, NAS, or EtOH for 1 h at the concentrations of 5 × 10−5 M (a,c) or 1 × 10−6 M (b,d). CM-H2DCFDA dye was added to the cells for 30 min and cells are further irradiated with 50 mJ/cm2 of UVB. ROS levels in melanocytes were determined 30 min after UVB irradiation. The differences in H2O2 production under different UVB intensities are shown as insert. Data are presented as percent of control and were analyzed using t-test, *p < 0.05, **p < 0.01, and ***p < 0.001.
Figure 5 Melatonin, NAS, 6-OHM, AFMK, and 5-MT reduce levels of ROS produced in UVB-irradiated melanocytes. Cells were treated without (a,b) or with (c,d) luzindole 1 h prior treatment with melatonin, AFMK, 6-OHT, 5-MT, NAS, or EtOH for 1 h at the concentrations of 5 × 10−5 M (a,c) or 1 × 10−6 M (b,d). CM-H2DCFDA dye was added to the cells for 30 min and cells are further irradiated with 50 mJ/cm2 of UVB. ROS levels in melanocytes were determined 30 min after UVB irradiation. The differences in H2O2 production under different UVB intensities are shown as insert. Data are presented as percent of control and were analyzed using t-test, *p < 0.05, **p < 0.01, and ***p < 0.001.CC BY · PubMed Central
Figure 6 Silencing of the NRF2 in human melanocytes reduced the effect of melatonin on the expression of NRF2 and NRF2-related genes: HO-1 and NQO2. Melanocytes were transfected with scrambled or NRF2 siRNA and treated with 5 × 10−5 M melatonin. Cells were lysed after treatment and total RNA extracted. NRF2 mRNA (a), HO-1 mRNA (b) and NQO2 (c) levels were measured using reagents for RTPCR and normalized relative to B-actin RNA. Levels of NRF2 and B-actin were assessed 72 h after transfection with NRF2 or scrambled siRNA, by western blotting of whole-cell extracts (insert).
Figure 6 Silencing of the NRF2 in human melanocytes reduced the effect of melatonin on the expression of NRF2 and NRF2-related genes: HO-1 and NQO2. Melanocytes were transfected with scrambled or NRF2 siRNA and treated with 5 × 10−5 M melatonin. Cells were lysed after treatment and total RNA extracted. NRF2 mRNA (a), HO-1 mRNA (b) and NQO2 (c) levels were measured using reagents for RTPCR and normalized relative to B-actin RNA. Levels of NRF2 and B-actin were assessed 72 h after transfection with NRF2 or scrambled siRNA, by western blotting of whole-cell extracts (insert).CC BY · PubMed Central
Figure 7 Melatonin, NAS, 6-OHM, AFMK, and 5-MT treated melanocytes increased NRF2 expression after UVB exposure. Melanocytes were exposed to UVB intensities of 0 or 50 mJ/cm2 and immediately treated with melatonin or its derivative for 24 h. Cells were further fixed and stained with anti-NRF2 antibody. Stained cells were imaged with a fluorescence microscope, fluorescence intensity was analysed using ImageJ software, and data are analysed using Graph Pad Prizm after 0 mJ/cm2 (a) and 50 mJ/cm2 (b). In addition, UVB diminishes NRF2 expression (insert). Data are presented as percentile of control and were analyzed using t- test, *p < 0.05, **p < 0.01.
Figure 7 Melatonin, NAS, 6-OHM, AFMK, and 5-MT treated melanocytes increased NRF2 expression after UVB exposure. Melanocytes were exposed to UVB intensities of 0 or 50 mJ/cm2 and immediately treated with melatonin or its derivative for 24 h. Cells were further fixed and stained with anti-NRF2 antibody. Stained cells were imaged with a fluorescence microscope, fluorescence intensity was analysed using ImageJ software, and data are analysed using Graph Pad Prizm after 0 mJ/cm2 (a) and 50 mJ/cm2 (b). In addition, UVB diminishes NRF2 expression (insert). Data are presented as percentile of control and were analyzed using t- test, *p < 0.05, **p < 0.01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 63 references

Research works printed but not linked: 1

  1. Slominski, A. T. D., Shibahara, S. & Wortsman, J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84, 1155–1228, doi:10.1152/physrev.00044.2003 (2004). · DOI · Paper page

Cited by

See all 163

Metadata

Authors
Janjetovic, Z., Jarrett, S. G., Lee, E. F., Duprey, C., Reiter, R. J., & Slominski, A. T.
Affiliations
  • University of Kentucky (US)
  • University of Tennessee Health Science Center (US)
  • The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Slominski, Andrzej T.
Venue
Scientific Reports
Published
2017-04-28
Volume
7
Issue
1
Pages
1274-1274
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2608477110
Cited by
163
References
63
Citations by year
2026: 8 · 2025: 11 · 2024: 18 · 2023: 16 · 2022: 16 · 2021: 20 · 2020: 24 · 2019: 21 · 2018: 25 · 2017: 4
FWCI
12.41
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UKnowledge (University of Kentucky) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR056666)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
Keywords
melatonin, melatonin metabolites, melanocytes, UV-B radiation, Nrf2, DNA repair, reactive oxygen species, oxidative stress, p53 phosphorylation, cyclobutane pyrimidine dimers, 6-4 photoproducts, skin photoprotection, melatonin receptors
MeSH terms
Cells, Cultured, DNA Repair, Humans, Melanocytes, Melatonin, Radiation-Protective Agents, Ultraviolet Rays, Reactive Oxygen Species, NF-E2-Related Factor 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melatonin and its metabolites protect human melanocytes against UVB-induced damage: Involvement of NRF2-mediated pathways. https://app.cochat.ai/papers/10.1038/s41598-017-01305-2
The paper
Janjetovic, Z., Jarrett, S. G., Lee, E. F., Duprey, C., Reiter, R. J., & Slominski, A. T. (2017). Melatonin and its metabolites protect human melanocytes against UVB-induced damage: Involvement of NRF2-mediated pathways. Scientific Reports. https://doi.org/10.1038/s41598-017-01305-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.